Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
Автори: | Mukhtyar, C, Luqmani, R |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2007
|
Схожі ресурси
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
за авторством: Mukhtyar, C, та інші
Опубліковано: (2008) -
Eular recommendations for vasculitis
за авторством: Luqmani, R, та інші
Опубліковано: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
за авторством: Mukhtyar, C, та інші
Опубліковано: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
за авторством: Mukhtyar, C, та інші
Опубліковано: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
за авторством: Mukhtyar, C, та інші
Опубліковано: (2009)